July 3, 2014

Contents of Subscription Rights to Shares (Stock Option Scheme as Stock-Linked Compensation Plan)

Astellas Pharma Inc. (Tokyo：4503, President and CEO: Yoshihiko Hatanaka, hereinafter called the "Company") today announced that it decided the contents of the subscription rights to shares to be offered to the Directors (except for the Outside Directors) and Corporate Executives of the Company, resolved at the meeting of the Board of Directors held on June 18, 2014.
Particulars
1. Name of subscription rights to shares to be offered:
Astellas Pharma Inc. Subscription Rights to Shares issued in July 2014
2. Total number of subscription rights to shares to be offered:
2,269 units (100 shares per subscription right to shares)
3. Type and number of shares to be issued upon exercise of subscription rights to shares: Shares of common stock of the Company: 226,900 shares
4. The amount to be paid for subscription rights to shares to be offered:
¥ 127,900 per subscription right to shares (option value: ¥ 1,279 per share)
(Note)
Besides above information, please refer to "Allotment of Subscription Rights to Shares (Stock Option
Scheme as Stock-Linked Compensation Plan)" issued on June 18, 2014.

#####
Contacts for inquiries or additional information
Astellas Pharma Inc. Corporate Communications
Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en/

distributed by